Does Maine Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Other indications only. Wegovy is a preferred cardiometabolic agent, with prior authorization for MACE reduction and MASH only. The criterion says it is not used for weight loss only

Does Maine Medicaid cover Mounjaro or Zepbound for weight loss?

Other indications only. Zepbound is covered with prior authorization for moderate to severe obstructive sleep apnea only, in adults with a BMI of 30 or more and AHI of 15 or more

Does Maine Medicaid cover Saxenda or Victoza for weight loss?

Not covered. Saxenda is not named on the PDL, and its weight-loss category says weight loss drugs are not covered

Medicaid coverage

Maine: what Medicaid covers

MaineCare’s July 1, 2026 preferred drug list covers Wegovy and Zepbound, but only for non-weight-loss indications. Wegovy is a preferred cardiometabolic agent limited to MACE reduction and MASH, and its criterion states it is not being used for weight loss only. Zepbound is limited to moderate to severe obstructive sleep apnea. Saxenda is not on the list, and the PDL’s weight-loss category says weight loss drugs are not covered.

Checked against the primary source August 27, 2026

What Medicaid in Maine covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Other indications only	Wegovy is a preferred cardiometabolic agent, with prior authorization for MACE reduction and MASH only. The criterion says it is not used for weight loss only Changed July 1, 2026
Tirzepatide	Other indications only	Zepbound is covered with prior authorization for moderate to severe obstructive sleep apnea only, in adults with a BMI of 30 or more and AHI of 15 or more Changed July 1, 2026
Liraglutide	Not covered	Saxenda is not named on the PDL, and its weight-loss category says weight loss drugs are not covered Changed July 1, 2026

Semaglutide Other indications only

Wegovy is a preferred cardiometabolic agent, with prior authorization for MACE reduction and MASH only. The criterion says it is not used for weight loss only

Changed July 1, 2026
Tirzepatide Other indications only

Zepbound is covered with prior authorization for moderate to severe obstructive sleep apnea only, in adults with a BMI of 30 or more and AHI of 15 or more

Changed July 1, 2026
Liraglutide Not covered

Saxenda is not named on the PDL, and its weight-loss category says weight loss drugs are not covered

Changed July 1, 2026

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
MaineCare Preferred Drug List (PDL), Effective July 1, 2026
Maine Department of Health and Human Services, Office of MaineCare Services (MaineCare PDL website) Primary text read and checked Checked August 27, 2026